The genetics and clinical manifestations of patients with vitamin D dependent rickets type 1A

J Pediatr Endocrinol Metab. 2021 Apr 7;34(6):781-789. doi: 10.1515/jpem-2020-0691. Print 2021 Jun 25.

Abstract

Objectives: Vitamin D dependent rickets type 1A (VDDR-1A) is a very rare autosomal recessive disorder caused by mutations in the CYP27B1, which encodes vitamin D 1α-hydroxylase. We report the genetics and clinical manifestations of nine patients with VDDR-1A and compare our patients to other cases with the same mutations in the literature.

Methods: The clinical presentations, clinical and laboratory findings and treatment modalities of the patients were evaluated retrospectively.

Results: The mean age of the patients at the time of diagnosis was 39.9 months (range: 4.5-111). At the time of diagnosis, six patients had received stoss vitamin D therapy. Clinical findings related to rickets were obvious in seven patients and unclear in two patients. Except for one case, all patients had laboratory findings of rickets. A novel variant and four previously reported mutations in CYP27B1 were identified. The mean calcitriol and elemental calcium dose were 45.5 ng/kg/day (range: 20-70) and 75.6 mg/kg/day (range: 45-125), respectively.

Conclusions: We found a novel compound heterozygous mutation consisting of a reported duplication [(p.F443Pfs*24 (c.1319_1325 dup CCCACCC)] in exon 8 and a novel deletion [p.D507Efs*34 (c.1521 delC)] in exon 9. Our study suggests that the clinical manifestations and laboratory findings of the patients with VDDR1A are variable even among the patients with the same mutation.

Keywords: 1α-hydroxylase; children; vitamin D dependent rickets type 1A.

MeSH terms

  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase / genetics*
  • Biomarkers / analysis*
  • Child
  • Child, Preschool
  • Familial Hypophosphatemic Rickets / drug therapy
  • Familial Hypophosphatemic Rickets / epidemiology*
  • Familial Hypophosphatemic Rickets / genetics*
  • Familial Hypophosphatemic Rickets / pathology
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Male
  • Mutation*
  • Prognosis
  • Retrospective Studies
  • Turkey / epidemiology
  • Vitamin D / administration & dosage*
  • Vitamins / administration & dosage

Substances

  • Biomarkers
  • Vitamins
  • Vitamin D
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase
  • CYP27B1 protein, human

Supplementary concepts

  • Vitamin D Hydroxylation-Deficient Rickets, Type 1A